US Tells High Court Myriad's Isolated DNA Can't Be Patented
The federal government told the U.S. Supreme Court on Thursday that breast cancer genes isolated by Myriad Genetics Inc. cannot be patented because they are no different from genes that exist...To view the full article, register now.
Already a subscriber? Click here to view full article